How Do Wegovy and Mounjaro Side Effects Actually Compare?
Does Wegovy Have Less Side Effects Than Mounjaro? Understanding Genuine Medication Profiles
When comparing whether Wegovy has less side effects than Mounjaro, authenticity matters significantly for safety outcomes. Genuine Novo Nordisk Wegovy contains precisely controlled semaglutide concentrations, whilst counterfeit versions flooding online markets may contain unknown substances or incorrect dosing. EverydayMeds sources directly from UK-licensed wholesalers, ensuring every FlexTouch pen meets MHRA manufacturing standards. Our batch-verification process allows patients to confirm authenticity through official Novo Nordisk channels.
The question "does Wegovy have less side effects than Mounjaro" requires understanding their different mechanisms. Wegovy targets GLP-1 receptors exclusively, whilst Mounjaro activates both GIP and GLP-1 pathways, potentially creating different tolerability patterns. Clinical data suggests comparable gastrointestinal side effects between both medications, though individual responses vary significantly. Both require careful dose escalation to minimise adverse effects, making prescriber guidance essential for optimal outcomes.
Wegovy vs Mounjaro Pricing: Genuine Medication Value Comparison
Understanding whether Wegovy has less side effects than Mounjaro involves considering cost-effectiveness alongside tolerability. Our genuine Novo Nordisk Wegovy starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. The Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing two months of initial treatment. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 for continued savings.
When evaluating does Wegovy have less side effects than Mounjaro, our pricing transparency helps patients make informed decisions. The Progress Trio bundle (0.5mg, 1mg & 1.7mg) costs £369.99, supporting gradual dose escalation that may reduce side effect severity. Our Consistency bundles offer repeated dosing at the same strength, useful if patients need extended periods at specific doses due to tolerability concerns. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity without supply interruptions.
Clinical Evidence: Wegovy vs Mounjaro Side Effect Profiles
Research examining whether Wegovy has less side effects than Mounjaro shows similar adverse event patterns in clinical trials. The STEP programme (Wilding et al., NEJM, 2021) demonstrated that Wegovy's most common side effects included nausea (44%), diarrhoea (30%), and vomiting (24%), typically occurring during dose escalation phases. These gastrointestinal effects generally decreased over time as patients developed tolerance to semaglutide.
Mounjaro's SURMOUNT trials revealed comparable side effect frequencies, with nausea affecting approximately 37-44% of participants depending on final dose achieved. The dual-agonist mechanism may theoretically provide different tolerability characteristics, though head-to-head comparative trials remain limited. Both medications carry similar contraindications and warnings, including potential thyroid C-cell tumour risks and pancreatitis concerns requiring careful patient selection.
How Wegovy Works: Understanding Side Effects Through Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural hormone GLP-1 that regulates blood sugar and gastric emptying after meals. This mechanism explains why nausea and gastrointestinal side effects occur, as the medication slows stomach emptying and enhances satiety signals to the brain. The once-weekly injection maintains steady semaglutide levels, which may help some patients tolerate side effects better than daily medications. Understanding this mechanism helps predict when side effects might occur and how they can be managed through timing of meals and dose escalation. The prescription-only medicine requires careful monitoring during initiation, as individual sensitivity to GLP-1 effects varies considerably between patients.
Ordering Genuine Wegovy: Safe Assessment and Delivery Process
Our streamlined process ensures patients receive authentic medication whilst addressing concerns about whether Wegovy has less side effects than Mounjaro through professional assessment. The 3-minute online clinical questionnaire evaluates medical history, current medications, and individual risk factors that might influence side effect likelihood. Our registered prescribers review applications within 3 working days (24 hours for express service), providing personalised guidance on dose escalation and side effect management. Once approved, next-day delivery uses temperature-controlled logistics maintaining the 2-8°C cold chain essential for semaglutide stability. Each package includes comprehensive patient information leaflets detailing side effect recognition and management strategies.
Storage Advantages: Wegovy's Practical Benefits Over Mounjaro
A practical consideration when evaluating does Wegovy have less side effects than Mounjaro involves storage convenience affecting treatment adherence. Genuine Novo Nordisk Wegovy FlexTouch pens remain stable for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. This storage advantage supports travel, workplace convenience, and reduces medication waste from temperature excursions. The pre-loaded FlexTouch pen design eliminates mixing errors that could theoretically affect side effect profiles with other injection systems. Weekly dosing schedules may also improve adherence compared to daily medications, potentially leading to more consistent blood levels and predictable side effect patterns.
Counterfeit Risks: Why Genuine Novo Nordisk Matters for Safety
The MHRA has issued specific warnings about counterfeit semaglutide products containing incorrect active ingredients, potentially causing unpredictable or dangerous side effects unrelated to genuine Wegovy. EverydayMeds' verification processes include batch number tracking, official packaging authentication, and supply chain documentation ensuring every pen originates from authorised UK wholesalers. Patients can verify their medication authenticity through Novo Nordisk's official verification tools using batch numbers and packaging security features.
When considering does Wegovy have less side effects than Mounjaro, medication authenticity significantly impacts safety profiles. Counterfeit products may contain varying concentrations, contaminated ingredients, or completely different substances masquerading as semaglutide. Our GPhC registration (#9012878) requires compliance with strict sourcing standards, protecting patients from these risks. The authentic Novo Nordisk FlexTouch pen includes distinctive design features, clear labelling, and consistent manufacturing quality ensuring predictable therapeutic effects.
Making Your Decision: Professional Support for Treatment Choice
Determining whether Wegovy has less side effects than Mounjaro requires individualised assessment considering medical history, previous medication tolerances, and lifestyle factors. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which option suits your specific circumstances best. Our clinical team provides ongoing support throughout treatment, helping patients navigate side effect management and dose adjustments as needed. Starting with genuine Novo Nordisk Wegovy from £79.99, new customers can begin their assessment today using code FIRST40 at checkout for immediate savings. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and receive expert guidance on the most appropriate treatment option for your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
